AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 152 filers reported holding AERIE PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $56,000 | +143.5% | 3,728 | +20.0% | 0.00% | +200.0% |
| Q2 2022 | $23,000 | -17.9% | 3,106 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $28,000 | +27.3% | 3,106 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $22,000 | -37.1% | 3,106 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $35,000 | -30.0% | 3,106 | 0.0% | 0.00% | -50.0% |
| Q2 2021 | $50,000 | -10.7% | 3,106 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $56,000 | +14.3% | 3,106 | -13.9% | 0.00% | 0.0% |
| Q4 2020 | $49,000 | +16.7% | 3,606 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $42,000 | -20.8% | 3,606 | 0.0% | 0.00% | -33.3% |
| Q2 2020 | $53,000 | +8.2% | 3,606 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $49,000 | -43.7% | 3,606 | 0.0% | 0.00% | -25.0% |
| Q4 2019 | $87,000 | +26.1% | 3,606 | 0.0% | 0.00% | +33.3% |
| Q3 2019 | $69,000 | -35.5% | 3,606 | 0.0% | 0.00% | -40.0% |
| Q2 2019 | $107,000 | -24.1% | 3,606 | +21.7% | 0.01% | -28.6% |
| Q1 2019 | $141,000 | +31.8% | 2,964 | 0.0% | 0.01% | +16.7% |
| Q4 2018 | $107,000 | -41.2% | 2,964 | 0.0% | 0.01% | -25.0% |
| Q3 2018 | $182,000 | -9.0% | 2,964 | 0.0% | 0.01% | -20.0% |
| Q2 2018 | $200,000 | +31.6% | 2,964 | +5.7% | 0.01% | +42.9% |
| Q1 2018 | $152,000 | -9.5% | 2,805 | 0.0% | 0.01% | -12.5% |
| Q4 2017 | $168,000 | +10.5% | 2,805 | +5.3% | 0.01% | +14.3% |
| Q3 2017 | $152,000 | +8.6% | 2,665 | 0.0% | 0.01% | 0.0% |
| Q2 2017 | $140,000 | +29.6% | 2,665 | +11.5% | 0.01% | +40.0% |
| Q1 2017 | $108,000 | – | 2,390 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|